Incidence and Risk Factors for Residual Adverse Events Despite Anticoagulation in Atrial Fibrillation: Results From Phase II/III of the GLORIA‐AF Registry

Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 1 news story.

Using data from the GLORIA-AF registry, researchers evaluated the incidence and risk factors for residual adverse events in…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.